• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

If CFS may have autoimmune aspects to it, is it dangerous for us to take immune modulators?

Mary

Moderator Resource
Messages
17,385
Location
Southern California
. Without a comparison to controls these figures tell us nothing and if deliberately presented without comparison to controls you can be pretty sure there was a reason - no difference.

Thanks for your reply. I was thinking perhaps the missing information would be provided in the full text of the article; unfortunately it costs $39.95 to get - I can't find a way to get it without paying for it. I really wanted to see if the full article had the data that was missing from the abstract.

FWIW, here is a study which does show andrographis having a significant effect in reducing fatigue associated with MS: https://www.ncbi.nlm.nih.gov/pubmed/27215274
 

voner

Senior Member
Messages
592
Thanks for your reply. I was thinking perhaps the missing information would be provided in the full text of the article; unfortunately it costs $39.95 to get - I can't find a way to get it without paying for it. I really wanted to see if the full article had the data that was missing from the abstract.

Mary,

this link's instructions will help you access that paper or any other paper.

http://forums.phoenixrising.me/inde...-sci-hub-if-youre-faced-with-a-paywall.49743/
 

Jonathan Edwards

"Gibberish"
Messages
5,256
Thanks for your reply. I was thinking perhaps the missing information would be provided in the full text of the article; unfortunately it costs $39.95 to get - I can't find a way to get it without paying for it. I really wanted to see if the full article had the data that was missing from the abstract.

FWIW, here is a study which does show andrographis having a significant effect in reducing fatigue associated with MS: https://www.ncbi.nlm.nih.gov/pubmed/27215274

Both studies come from somebody called Burgos in Chile. The MS abstract does not give data in the sort of form I would expect from a reliable source. It does not say much at all - and again it gives a misleading figure of 44%, which is not the one we want. We want the difference between treatment and control. The theoretical justification for using the compound does not seem to bear any relation to reducing fatigue. I would be surprised if these data are meaningful. I am afraid that 80% of studies like this are not.